These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10895191)
1. Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patients. Carr BI; Dvorchik I Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():432-5. PubMed ID: 10895191 [No Abstract] [Full Text] [Related]
2. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Carr BI Hepatogastroenterology; 2002; 49(43):79-86. PubMed ID: 11941989 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study of the effect of cisplatin therapy in unresectable hepatocellular carcinoma]. Matsuki S; Sugimoto M; Nii S; Kokubu S; Yamada N; Ishii K; Shibata H; Okabe H Gan To Kagaku Ryoho; 1988 Jan; 15(1):53-7. PubMed ID: 2827586 [TBL] [Abstract][Full Text] [Related]
5. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy]. Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma. Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil. Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527 [TBL] [Abstract][Full Text] [Related]
9. Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma. Nagai H; Matsui T; Kanayama M; Wakui N; Momiyama K; Watanabe M; Igarashi Y; Sumino Y Cancer Chemother Pharmacol; 2011 Jul; 68(1):139-45. PubMed ID: 20857114 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis. Wen J; Shen WL; Yang SH Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580 [TBL] [Abstract][Full Text] [Related]
11. [A case of hepatocellular carcinoma with liver cirrhosis type C surviving over 2 years by repeated transarterial infusion therapy using cisplatinum]. Miura T; Tsuboi Y; Takano T; Ozeki Y; Nakamura J; Yamada S; Miura T; Yanagi M; Takahashi T Gan To Kagaku Ryoho; 2009 Aug; 36(8):1347-9. PubMed ID: 19692776 [TBL] [Abstract][Full Text] [Related]
12. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis]. Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607 [TBL] [Abstract][Full Text] [Related]
13. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209 [TBL] [Abstract][Full Text] [Related]
14. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis. Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684 [TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors. Lu W; Li Y; He X; Chen Y Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468 [TBL] [Abstract][Full Text] [Related]
16. [DDP-H, new formulation of cisplatin for hepatic artery infusion therapy]. Furue H Nihon Rinsho; 2001 Oct; 59 Suppl 6():670-3. PubMed ID: 11762034 [No Abstract] [Full Text] [Related]